SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis
Clinical trial NCT03136861 · COMPLETED
Trial details
- NCT number
- NCT03136861
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-30
- Primary completion
- 2019-02-15
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.